Seeking Alpha

The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%)...

The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%) shareholders over whether the company made "potentially materially false and misleading" statements about its prospects and operations. The announcement cites the long run-up in Celgene's shares before they plunged following a regulatory setback for its Revlimid drug.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs